Your browser doesn't support javascript.
loading
Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants.
Blanken, Maarten O; Frederix, Geert W; Nibbelke, Elisabeth E; Koffijberg, Hendrik; Sanders, Elisabeth A M; Rovers, Maroeska M; Bont, Louis.
Afiliação
  • Blanken MO; Division of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, P.O. Box 85090, 3508 AB, Utrecht, the Netherlands.
  • Frederix GW; Division Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Nibbelke EE; Division of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, P.O. Box 85090, 3508 AB, Utrecht, the Netherlands.
  • Koffijberg H; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands.
  • Sanders EAM; Division of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, P.O. Box 85090, 3508 AB, Utrecht, the Netherlands.
  • Rovers MM; Departments of Epidemiology, Biostatistics and HTA, and Operating Rooms, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
  • Bont L; Division of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, P.O. Box 85090, 3508 AB, Utrecht, the Netherlands. l.bont@umcutrecht.nl.
Eur J Pediatr ; 177(1): 133-144, 2018 Jan.
Article em En | MEDLINE | ID: mdl-29168012
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Custos de Cuidados de Saúde / Análise Custo-Benefício / Infecções por Vírus Respiratório Sincicial / Palivizumab / Doenças do Prematuro Tipo de estudo: Clinical_trials / Diagnostic_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Newborn País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Custos de Cuidados de Saúde / Análise Custo-Benefício / Infecções por Vírus Respiratório Sincicial / Palivizumab / Doenças do Prematuro Tipo de estudo: Clinical_trials / Diagnostic_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Newborn País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article